Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-05-12

Clinical Trial Update: Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing clobetasol propionate with pimecrolimus for vulvar lichen sclerosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clobetasol (clobetasol)
  • Elidel (pimecrolimus)

Snippet

Sponsor: Center for Vulvovaginal Disorders | Conditions: Lichen Sclerosus | Phase 2 | Status: COMPLETED